![Mark W. Schwartz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark W. Schwartz
Presidente presso MWS Strategic Advisors LLC
Profilo
Mark W.
Schwartz is currently the Chairman of MWS Strategic Advisors LLC, Director of Biotechnology Innovation Organization, Director of NeoLight LLC, and Independent Director of SquareX Pharmaceuticals Corp.
He was previously the President & CEO of Bayhill Therapeutics, President, CEO & Director of Galena Biopharma, President & CEO of Apthera, President & CEO of Calyx Therapeutics, Managing Director-Life Sciences of Arizona Science & Technology Enterprises LLC, Executive Director of Targazyme, and Chief Commercial Officer of Trega Biosciences.
He also served as the COO & Executive VP of Phio Pharmaceuticals Corp.
Schwartz holds a doctorate from Arizona State University and an undergraduate degree from Grinnell College.
Posizioni attive di Mark W. Schwartz
Società | Posizione | Inizio |
---|---|---|
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Direttore/Membro del Consiglio | - |
SquareX Pharmaceuticals Corp.
![]() SquareX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Squarex Pharmaceutical Corp. engages in the research and development of pharmaceutical products. It focuses on the late-clinical-stage drug that is intended to improve immune function to reduce severity and incidence of infectious disease. The company was founded on June 26, 2012 and is headquartered in St. Paul, MN. | Direttore/Membro del Consiglio | 01/11/2022 |
MWS Strategic Advisors LLC | Presidente | - |
NeoLight LLC
![]() NeoLight LLC Medical SpecialtiesHealth Technology NeoLight LLC provides technology solutions. The company was founded by Vivek Kopparthi, Chase Garrett and Sivakumar Palaniswamy and is headquartered in Scottsdale, AZ. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Mark W. Schwartz
Società | Posizione | Fine |
---|---|---|
Galena Biopharma, Inc.
![]() Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Amministratore Delegato | 31/01/2017 |
Arizona Science & Technology Enterprises LLC | Corporate Officer/Principal | 01/01/2004 |
Calyx Therapeutics, Inc.
![]() Calyx Therapeutics, Inc. Medical/Nursing ServicesHealth Services Calyx Therapeutics, Inc. provides therapies services for diabetes and inflammatory diseases. The company is based in Hayward, CA. The company was founded by Somesh Datt Sharma. | Presidente | 01/01/2003 |
Trega Biosciences, Inc.
![]() Trega Biosciences, Inc. BiotechnologyHealth Technology Trega Biosciences, Inc. was a drug discovery company, utilizing combinatorial chemistry and other technologies to pursue the discovery of novel, small-molecule drug therapies. The company leveraged its technology platform by entering into pharmaceutical alliances, enabling partners to access its technologies in exchange for licensing fees and potential milestone payments and royalties or by establishing joint-discovery alliances with biotechnology companies. The company used its drug discovery technologies in its internal development programs. It was headquartered in San Diego, CA. The compnay was acquired by LION bioscience AG | Corporate Officer/Principal | 01/01/2001 |
Targazyme, Inc.
![]() Targazyme, Inc. BiotechnologyHealth Technology Targazyme, Inc. operates as a biotechnology company. It develops and commercializes breakthrough products. The firm offers products for stem cell transplantation, immunotherapy for cancer, regenerative medicine, and gene therapy. The company was founded by Lynnet Koh and is headquartered in Carlsbad, CA. | Direttore/Membro del Consiglio | - |
Formazione di Mark W. Schwartz
Arizona State University | Doctorate Degree |
Grinnell College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
PHIO PHARMACEUTICALS | Health Technology |
Aziende private | 11 |
---|---|
Trega Biosciences, Inc.
![]() Trega Biosciences, Inc. BiotechnologyHealth Technology Trega Biosciences, Inc. was a drug discovery company, utilizing combinatorial chemistry and other technologies to pursue the discovery of novel, small-molecule drug therapies. The company leveraged its technology platform by entering into pharmaceutical alliances, enabling partners to access its technologies in exchange for licensing fees and potential milestone payments and royalties or by establishing joint-discovery alliances with biotechnology companies. The company used its drug discovery technologies in its internal development programs. It was headquartered in San Diego, CA. The compnay was acquired by LION bioscience AG | Health Technology |
Bayhill Therapeutics, Inc.
![]() Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bayhill Therapeutics, Inc. develops and commercializes therapeutics. Its technology is BHT-DNA. The firm is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA platform to develop a pipeline of novel and targeted treatment candidates for autoimmune diseases. Bayhill Therapeutics was founded by Lawrence Steinman, Hideki Garren, William H. Robinson and Paul J. Utz in 2001 and is headquartered in Palo Alto, CA. | Health Technology |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Galena Biopharma, Inc.
![]() Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |
Apthera, Inc.
![]() Apthera, Inc. Medical/Nursing ServicesHealth Services Apthera, Inc. develops a pipeline of peptide-based immunotherapies for cancers. It has products in clinical trials aimed at reducing disease recurrence rates for breast, prostate, and pancreatic cancers. The company was founded Robert E. Kennedy, William Gannon, and Joseph Sinkule in July, 2005 and is headquartered in Scottsdale, AZ. | Health Services |
Arizona Science & Technology Enterprises LLC | |
Calyx Therapeutics, Inc.
![]() Calyx Therapeutics, Inc. Medical/Nursing ServicesHealth Services Calyx Therapeutics, Inc. provides therapies services for diabetes and inflammatory diseases. The company is based in Hayward, CA. The company was founded by Somesh Datt Sharma. | Health Services |
Targazyme, Inc.
![]() Targazyme, Inc. BiotechnologyHealth Technology Targazyme, Inc. operates as a biotechnology company. It develops and commercializes breakthrough products. The firm offers products for stem cell transplantation, immunotherapy for cancer, regenerative medicine, and gene therapy. The company was founded by Lynnet Koh and is headquartered in Carlsbad, CA. | Health Technology |
NeoLight LLC
![]() NeoLight LLC Medical SpecialtiesHealth Technology NeoLight LLC provides technology solutions. The company was founded by Vivek Kopparthi, Chase Garrett and Sivakumar Palaniswamy and is headquartered in Scottsdale, AZ. | Health Technology |
SquareX Pharmaceuticals Corp.
![]() SquareX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Squarex Pharmaceutical Corp. engages in the research and development of pharmaceutical products. It focuses on the late-clinical-stage drug that is intended to improve immune function to reduce severity and incidence of infectious disease. The company was founded on June 26, 2012 and is headquartered in St. Paul, MN. | Health Technology |
MWS Strategic Advisors LLC |
- Borsa valori
- Insiders
- Mark W. Schwartz